Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Single-Blind, Placebo-Controlled Study Evaluating the Cardiovascular Properties of MANP in African Americans With Hypertension

NCT04542681 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04542681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04542681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Single-Blind, Placebo-Controlled Study Evaluating the Cardiovascular Properties of MANP in African Americans With Hypertension
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Withdrawn
Start date
May 1, 2018
Completion date
June 30, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, resistant to conventional therapy